Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,000 | 0,000 | 19.08. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | NanoVibronix Shares Slide 10% Despite Patent Grant | - | RTTNews | ||
Do | NanoVibronix receives patent for medical imaging navigation overlay | 1 | Investing.com | ||
19.08. | NanoVibronix, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
12.08. | XFRA 56R1: AUSSETZUNG/SUSPENSION | 511 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNANOVIBRONIX NEW... ► Artikel lesen | |
12.08. | XFRA NEW INSTRUMENTS AVAILABLE ON 12.08.2025 | 170 | Xetra Newsboard | The following instruments on XETRA do have their first trading 12.08.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 12.08.2025
Aktien
1 CA00810E2087 Aether Global Innovations... ► Artikel lesen | |
11.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.08.2025 | 480 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 11.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.08.2025.ISIN NameAU000000EVS3 ENVIROSUITE... ► Artikel lesen | |
NANOVIBRONIX Aktie jetzt für 0€ handeln | |||||
11.08. | XFRA ISIN CHANGE | 227 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA00810E1097 Aether Global Innovations Corp. 11.08.2025 CA00810E2087 Aether Global Innovations Corp. 12.08.2025 Tausch... ► Artikel lesen | |
08.08. | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
08.08. | NanoVibronix announces another reverse stock split | 6 | MassDevice | ||
08.08. | NanoVibronix announces 1-for-10 reverse stock split effective August 11 | 6 | Investing.com | ||
08.08. | NanoVibronix, Inc. Announces Reverse Stock Split | 165 | Business Wire | Common Stock Will Begin Trading on Split-Adjusted Basis on August 12, 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company"), a medical technology... ► Artikel lesen | |
30.07. | NanoVibronix, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
18.07. | NanoVibronix-Aktionäre geben grünes Licht für Aktienzusammenlegung | 12 | Investing.com Deutsch | ||
18.07. | NanoVibronix, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
18.07. | NanoVibronix enters into $50M financing agreement | 2 | MassDevice | ||
18.07. | NanoVibronix sichert sich Finanzierung über 8 Millionen US-Dollar mit Option auf Aufstockung | 2 | Investing.com Deutsch | ||
18.07. | NanoVibronix secures $8 million in funding, with potential for more | 1 | Investing.com | ||
11.07. | NanoVibronix vertagt außerordentliche Hauptversammlung mangels Beschlussfähigkeit | 4 | Investing.com Deutsch | ||
09.07. | NanoVibronix korrigiert Mindestpreis für Vorzugsaktien der Serie G | 2 | Investing.com Deutsch | ||
09.07. | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 47,240 | -0,63 % | Siemens Healthineers-Aktie leicht im Minus (46,38 €) | Im Minus liegt gegenwärtig die Aktie von Siemens Healthineers . Der jüngste Kurs betrug 46,38 Euro. Am deutschen Aktienmarkt hat sich heute der Anteilsschein von Siemens Healthineers zwischenzeitlich... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,111 | +0,91 % | Sernova Corp.: Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference | ||
BECTON DICKINSON | 163,60 | +0,43 % | Dividendenbekanntmachungen (08.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALPHABET INC CDR CA02080K1049 0,0341 CAD 0,0211 EUR ALPHABET INC CL A US02079K3059 0,21 USD 0,1791 EUR ALPHABET INC CL C US02079K1079 0... ► Artikel lesen | |
NUGEN MEDICAL DEVICES | 0,031 | -3,12 % | Massive News: Volumen- und Kursexplosion durch "InsuJet 2.0"?! | ||
ATOSSA THERAPEUTICS | 0,680 | -1,02 % | Atossa Genetics stock rating reiterated by H.C. Wainwright on FDA meeting plans | ||
SPINEWAY | 0,120 | +2,03 % | Spineway: H1 2025 results - Continued improvement in results and financial position | Press release Ecully, July 30, 2025 - 7 p.m. SPINEWAY H1 2025 results Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of... ► Artikel lesen | |
PING AN HEALTHCARE | 2,400 | +3,23 % | HSI Closes at 25,343, Down 153 pts; HSTI Closes at 5,683, Down 44 pts; BYD ELECTRONIC Down over 4%; CSPC PHARMA, CHOW TAI FOOK, MEDBOT-B, PA GOODDOCTOR, WUXI XDC Hit New Highs; Market Turnover Rises | ||
MOUNTAIN VALLEY MD | 0,015 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,260 | -2,99 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
VERU | 3,470 | +3,27 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
CYTOSORBENTS | 0,859 | +2,26 % | CytoSorbents bei H.C. Wainwright: Strategisches Wachstum und regulatorische Herausforderungen | ||
LIFEWARD | 0,550 | 0,00 % | Lifeward Ltd.: Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
VOLITIONRX | 0,620 | 0,00 % | VolitionRx vergibt Forschungslizenz für APS-Test an Werfen | ||
EKSO BIONICS | 4,070 | -1,45 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen |